ArticleFrontiers in oncology2020

A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer.

Wenfang Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.